Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer. Schmid P, Cortes J, Dent R, Pusztai L, et al. N Engl J Med 2022;386:556-567.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schmid P, Cortes J, Dent R, Pusztai L, et al. Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer. N Engl J Med 2022;386:556-567.
PMID: 35139274